EUVIMEDEUVIMED entdecken
Open Access

Inhibition of Phosphorylated Alpha-Synuclein Aggregation by Synthetic Protein Mimetics and Foldamers

Emily G Oldani iD, Nicholas H Stillman iD, Ryan A Dohoney iD, Charles Zuwu Baysah, Sunil Kumar iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.4c00546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Emily G Oldani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado 80210, United States. Hauptthemen laut MEDLINE: alpha-Synuclein, Protein Aggregation, Pathological. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, American Parkinson's Disease Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The formation of Lewy bodies (LB) is a pathological hallmark for synucleinopathies, which is an umbrella term for many diseases, including Parkinson's disease, Lewy body dementia, and multiple system atrophy. One of the main components of LB is the aggregates of phosphorylated modification of α-Synuclein at residue 129 (αS-129), a neuronal protein expressed in the dopaminergic neurons in the brain. There are equivocal results about the role of αS-129, suggesting its involvement in both potentiating pathology and a functional role to rescue pathology. Regardless, a potential therapeutic strategy for LB-based pathologies could be the identification of inhibitors of both αS and αS-129 aggregation. However, to the best of our knowledge, there are no reports of ligands that can potently inhibit the aggregation of αS-129. Our group has recently identified potent antagonists of αS aggregation based on the oligopyridylamide (synthetic protein mimetics) and oligoquinoline (foldamers) scaffolds. Both ligands were potent antagonists of αS aggregation-mediated disease phenotypes in various PD models. Here, we tested both ligands against αS-129 aggregation and the coaggregation of αS and αS-129 (αS/αS-129). Both ligands were potent antagonists of αS-129 aggregation and coaggregation of αS/αS-129 in biophysical and cellular models of PD. Both ligands rescued cell toxicity mediated by the coaggregation of αS/αS-129. To the best of our knowledge, these are the first ligands that potently inhibit the major component of LB. This finding will aid in the development of therapeutic insights into aggregation-related synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinProtein Aggregation, PathologicalHumansPhosphorylationProtein AggregatesLewy BodiesAnimals

Stichwörter der Autor:innen

Lewy bodiesalpha-synucleinoligopyridylamidesoligoquinolinesphosphorylated S129protein mimetics

Substanzen

alpha-SynucleinProtein Aggregates

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Denver, Denver, Colorado 80210, United States.
  • The Knoebel Institute for Healthy Aging, University of Denver, Denver, Colorado 80210, United States.
  • Molecular and Cellular Biophysics Program, University of Denver, Denver, Colorado 80210, United States.

ORCID-Profile: Emily G Oldani, Nicholas H Stillman, Ryan A Dohoney, Sunil Kumar

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • American Parkinson's Disease Foundation
  • University of Denver
  • Parkinson's Foundation
  • Knoebel Institute for Healthy Aging

Zitieren

APA

Oldani, E. G., Stillman, N. H., Dohoney, R. A., Baysah, C. Z., & Kumar, S. (2025). Inhibition of Phosphorylated Alpha-Synuclein Aggregation by Synthetic Protein Mimetics and Foldamers. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00546

Vancouver

Oldani EG, Stillman NH, Dohoney RA, Baysah CZ, Kumar S. Inhibition of Phosphorylated Alpha-Synuclein Aggregation by Synthetic Protein Mimetics and Foldamers. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00546

BibTeX
@article{Oldani2025,
  author = {Oldani, Emily G and Stillman, Nicholas H and Dohoney, Ryan A and Baysah, Charles Zuwu and Kumar, Sunil},
  title = {Inhibition of Phosphorylated Alpha-Synuclein Aggregation by Synthetic Protein Mimetics and Foldamers},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.4c00546}
}
Kostenlos starten →